Aspiro Therapeutics to Present at Biotech Showcase™ 2025
Pioneering a Novel Disease-Modifying Therapy for Obstructive Lung Disease San Francisco, CA / Jan. 8 2025—Aspiro Therapeutics, an innovator developing an advanced, disease-modifying therapy that targets obstructive lung diseases, today announced that its CEO, James Lovgren, will present at Seed Showcase™, part of Biotech Showcase 2025. The presentation, “A Novel Therapy to Treat Obstructive […]